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ABSTRACT
The adenovirus genome forms chromatin-like struc-
ture with viral core proteins. This complex supports
only a low level of transcription in a cell-free system,
and thus core proteins have been thought to be
negative factors for transcription. The mechanism
how the transcription from the viral DNA complexed
with core proteins is activated in infected cells
remains unclear. Here, we found that both core
proteins and histones are bound with the viral DNA
in early phases of infection. We also found that
acetylation of histone H3 occurs at the promoter
regions of viral active genes in a transcription-
independent manner. In addition, when a plasmid
DNA complexed with core proteins was introduced
into cells, core proteins enhanced transcription.
Knockdown of TAF-I, a remodeling factor for viral
core protein–DNA complexes, reduces the enhance-
ment effect by core proteins, indicating that
core proteins positively regulate viral transcription
through the interaction with TAF-I. We would
propose a possible mechanism that core proteins
ensure transcription by regulating viral chromatin
structure through the interaction with TAF-I.
INTRODUCTION
The adenovirus (Ad) genome is a linear double-stranded
DNA of  36000bp in length and is covalently bound
with terminal proteins (TP) at each 50-terminus. In the
virion, it forms a chromatin-like complex, designated
Ad-core, with viral basic core proteins VII, V and poly-
peptidem. Protein VII is a major component of Ad-core
and has limited amino acid sequence homology with pro-
tamine, a sperm-speciﬁc basic protein (1). In puriﬁed
Ad-core, protein VII is bound to the viral DNA most
tightly and seems to be the only protein component of
‘beads-on-a-string’ structure (2). Although the precise
structure of protein VII–DNA complexes is not clear,
protein VII could introduce superhelical turns into
DNA, as do cellular histones (3). Protein V is less tightly
associated with protein VII–DNA complexes and seems to
tether them to the capsid structure (4,5). Polypeptidem has
a strong ability to condense DNA (6).
The nuclear import of the viral genome occurs through
nuclear pore complexes (NPC), concomitantly with disas-
sembly of the virion (7). After the entry of the viral
genome into the nucleus, protein V seems to be dissociated
from viral chromatin (8). On the other hand, protein VII
remains associated with the viral DNA during early
phases of infection, suggesting that at least protein VII
is a component of viral template for early transcription
and DNA replication in infected cells (9,10). However,
core proteins function as repressors for transcription and
replication in ‘cell-free’ systems (11,12). It is also reported
that the expression of protein VII leads to condensation of
DNA and appears to repress transcription in Xenopus
oocytes (13). Thus, protein VII is thought to be a
negative factor for genome functions. However, the
exact role of protein VII in infected cells remains to be
determined. Viral genes are expressed with the temporal
regulation and divided into two major groups, early and
late genes. In early phase of infection, viral early genes
(e.g. E1A, E3 and E4 genes) are actively transcribed,
whereas late genes (e.g. MLP, IVa2 genes) are kept
silent in that time, and then activated concomitantly
with the onset of viral DNA replication.
We have identiﬁed Template Activating Factor (TAF)-
I, TAF-II/NAP-1 and TAF-III/nucleophosmin/B23 from
uninfected HeLa cell extracts as stimulatory factors in
‘cell-free’ Ad DNA replication and transcription systems
using Ad-core as a template (11,14–17). Biochemical
analyses revealed that TAF-I forms a stoichiometric
complex with protein VII–DNA complexes and enhances
the nuclease sensitivity of Ad-core, suggesting that TAF-I
remodels Ad-core by formation of ternary complexes,
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Ad-core (10,18). In good agreement with the biochemical
results, TAF-I is bound to viral chromatin through the
interaction with protein VII during early phases of infec-
tion in infected cells (10). Knockdown (KD) of TAF-I
expression results in reduction of the expression level
of viral early genes, suggesting that TAF-I plays an im-
portant role in early phases of infection in infected cells
(19). In addition to its role in Ad life cycle, it is shown that
TAF-I regulates the cellular gene expression through its
histone chaperone activity. TAF-I binds to histones
directly and remodels chromatin template in a ‘cell-free’
system (20). It is shown that TAF-I stimulates a subset of
genes in a histone acetylation-independent manner (21).
TAF-I is also reported as a component of an inhibitor
of the histone acetyltransferase complex (INHAT) (22).
TAF-III/nucleophosmin/B23 is a nucleolar protein and
functions as a histone chaperone for the regulation of
rRNA gene expression (23). Recently, we have reported
that B23 interacts with core protein V and a precursor
protein of protein VII in late phases of infection, and
has a potential role for viral chromatin assembly (24).
Association of cellular histones with the viral genome
DNA in infected cells remains controversial. It was shown
that the nucleosome-like ladder of intranuclear viral DNA
is generated by micrococcal nuclease (MNase) digestion,
indicating the possibility that core proteins are replaced
with cellular histones during early phases of infection
(25–27). On the other hand, in the UV cross-linking ex-
periments, no interaction between viral DNA and cellular
histones was observed during early phases of infection (9).
To clarify the structure of viral chromatin in infected cells,
we performed chromatin immunoprecipitation (ChIP)
assays and found that viral chromatin is associated with
both viral protein VII and cellular histones with post-
translational modiﬁcation (acetylation of histone H3) in
infected cells. In addition, by introducing puriﬁed Ad-core
or reconstituted protein VII–DNA complexes into cells,
we found that protein VII enhances transcription and
TAF-I is required for this effect of protein VII, but not
for the binding or acetylation of histone H3. Taken
together, the results obtained here suggest that viral tran-
scription is positively regulated by protein VII and a host
factor. We would propose a possible mechanism that core
proteins ensure transcription by regulating viral chroma-
tin structure through the interaction with TAF-I.
MATERIALS AND METHODS
Cells and viruses
The monolayer cultures of HeLa cells and TAF-I KD
HeLa cell lines (clones 4 and 7) (19) were maintained at
37 C in minimal essential medium (MEM; Nissui) con-
taining 10% fetal calf serum and used for all experiments
in this study. Puriﬁcation and infection of human adeno-
virus type 5 (HAdV5) were carried out essentially as
described earlier (19). Hydroxyurea and a-amanitin
(Sigma) were added at the ﬁnal concentration of 2mM
and 25mg/ml right after infection when DNA replication
and transcription were to be blocked, respectively.
siRNA-mediated knockdown of TAF-I expression
TAF-I Stealth siRNA and negative control Stealth siRNA
(Invitrogen) were introduced into HeLa cells with
Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s protocol. After incubation for 3 days, the reduc-
tion of the expression level of TAF-I was conﬁrmed by
western blot analysis using rabbit anti-TAF-Ia/b antibody
(see below).
Antibodies
Antibodies used in this study are as follows: rat antiprotein
VII (10), mouse anti-TAF-Ib (KM1720) (28), rabbit
antihistone H3 (catalog no. ab1791; abcam), antiacetylated
histone H3 (catalog no. 06-599; Millipore), mouse anti-
FLAG M2 (catalog no. F3165; Sigma), mouse anti-
b-actin (Sigma), rabbit anti-Hsp90 [kindly provided by
Drs Y. Miyata and E. Nishida (Kyoto University)],
rabbit anti-RNA polymerase II (N-20, catalog no. sc-899;
santa cruz biothechnology) and rabbit anti-Sp1 (catalog
no. 07-645; Millipore) antibodies. Rabbit anti-TAF-Ia/b
antibody was raised against His-tagged TAF-IbC3
(29) and puriﬁed with antigen-coupled afﬁnity column
according to standard protocols.
Recombinant proteins
Preparation of recombinant protein VII was carried out as
described earlier (10,18).
Transfection of Ad-core, TP-DNA and reconstituted
complexes
Ad-core and TP-DNA were puriﬁed from virions as
described earlier (11). Brieﬂy, Ad virions were puriﬁed
by centrifugation in CsCl solution, followed by dialysis
against 10mM Tris–HCl (pH 7.9) and 1mM EDTA as
described earlier. For the puriﬁcation of Ad-core, virions
were heated at 56 C for 60s in the presence of 0.5%
sodium deoxycholate and immediately chilled on ice,
and then Ad-core was puriﬁed by centrifugation in a
15–60% glycerol density gradient in 10mM Tris–HCl
(pH 7.9) and 1mM EDTA. For the puriﬁcation of
TP-DNA, virions were denatured with guanidine hydro-
chloride (GuHCl) at the ﬁnal concentration of 4M.
TP-DNA was puriﬁed by centrifugation in a 5–20%
sucrose gradient in 10mM Tris–HCl (pH 7.9), 1mM
EDTA, 4M GuHCl and 2mM b-mercaptoethanol and
dialyzed against 10mM Tris–HCl (pH 7.9), 1mM
EDTA and 20% glycerol. For reconstitution of protein
VII–DNA complexes, pSV-Luc (PGV-C, TOYO INK,
100ng) DNA and recombinant proteins were incubated
in a buffer containing 40mM Tris–HCl (pH 7.9),
150mM NaCl and 12.5% glycerol at 37 C for 15min,
and formed complexes were conﬁrmed by a 1% agarose
gel electrophoresis in 0.5 TBE (Tris–borate/EDTA).
HeLa cells were transfected with Ad-core, TP-DNA, or
the reconstituted complexes (100ng DNA) using
GeneJuice (Novagen) according to the manufacturer’s
protocol. For separation of cytoplasmic and nuclear frac-
tions, transfected cells were lysed with a buffer containing
10mM Tris–HCl (pH 7.9), 100mM NaCl, 3mM MgCl2
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fraction was recovered as a cytoplasmic fraction, while
the pellet was resuspended in the same buffer and used
as a nuclear fraction. To conﬁrm the separation proced-
ure, each fraction was subjected to a 12.5% SDS–PAGE,
followed by western blot analyses using anti-Hsp90 and
antihistone H3 antibodies. Cytoplasmic or nuclear DNA
was recovered from each fraction and subjected to PCR
using the speciﬁc primers for the MLP or SV40 promoter
regions where described.
ChIP assays
ChIP assays were carried out according to the protocol
from Chromatin Immunoprecipitation Assay Kit
(catalog no. 17-295; Millipore) with minor modiﬁcation.
Elution buffer used in this study contains 1% SDS,
100mM NaHCO3 and 10mM DTT. The recovered
DNA was ampliﬁed by PCR using Paq5000 DNA poly-
merase (Agilent Technologies) or KOD plus DNA poly-
merase (Toyobo) with the primer sets according to the
manufacturers’ protocols. The primers used here were as
follows: 50-GGGTCAAAGTTGGCGTTTTA-30 and 50-C
AAAATGGCTAGGAGGTGGA-30 for the E1A
promoter region, 50-AAGTTCAGATGACTAACTCAG
GGG-30 and 50-AGAGTTAGGATTGCCTGACGAG-30
for the E3 promoter region, 50-CCATAACAGTCAGCCT
TACCAGT-30 and 50-GTGACGATTTGAGGAAGT
TGTG-30 for the E4 promoter region, 50-AGGTGATTG
GTTTGTAGGTGTAGG-30 and 50-CTCCTCGTTTTTG
GAAACTGAC-30 for the MLP region, 50-CGCAGTGGT
CTTACATGCAC-30 and 50-CACACGGTTATCACCCA
CAG-30 for the hexon ORF region, 50-ATTCTCCGCCC
CATGGCTGAC-30 and 50-GGCGTCTTCCATTTTACC
AACAGTACC-30 for the SV40 promoter region, and 50-C
TGGCGAACTACTTACTCTAGCTT-30 and 50-GTGTA
GATAACTACGATACGGGAGG-30 for the b-lactamase
(Amp
r) ORF region. PCR products were separated on a
7% PAGE gel and visualized by staining with EtBr. The
quantitative PCR (qPCR) was performed using FastStart
SYBR Green Master (Roche) and Thermal Cycler Dice
Real Time System (Takara) according to the manufactur-
er’s protocol. The reaction condition was as follows:
polymerase-activating step (95 C for 10min), followed
by ampliﬁcation step (95 C for 10s, 56 C for 20s, and
72 C for 20s) 40 cycles. The results were analyzed
using Thermal Cycler Dice Real Time System Software
Ver. 2.10 (Takara). In all the experiments with qPCR,
mean values with SD were obtained from three independ-
ent experiments. Re-ChIP assays were performed by the
same protocol, except that the primary immunocomplex
obtained using the ﬁrst antibody was diluted 25-fold with
ChIP dilution buffer (16.7mM Tris–HCl (pH 7.9), 1.2mM
EDTA, 167mM NaCl, 1.1% Triton X-100 and 0.01%
SDS), and then subjected to immunoprecipitation with
the second antibody.
RT–PCR
Cells were collected into tubes, quickly frozen by liquid
N2 and stored at  80 C just before RNA extraction.
RNA extraction was performed according to the
standard protocol for the acid guanidium thiocyanate-
phenol chloroform method within 12h after sample
collection. RNAs were treated with DNase I (Invitrogen)
at 37 C for 30min, followed by phenol/chloroform
extraction. After ethanol precipitation, the concentration
and the A260/A280 ratio of RNA samples were measured
using NanoDrop (Thermo Scientiﬁc). cDNA was
synthesized from total RNA (1mg) using ReverTraAce
(Toyobo) and oligo-dT primer according to the manufac-
turer’s protocol, and stored at  30 C. RT–PCR was
performed using speciﬁc primer sets as follows: 50-AT
GGGTCAGAAGGATTCCTATGT-30 and 50-GGTCAT
CTTCTCGCGGTT-30 for b-actin, 50-GAGACATATTA
TCTGCCACGGAG-30 and 50-AGTGAGTAAGTCAAT
CCCTTCCTG-30 for E1A, 50-AATCCTAGGTTTACTC
ACCCTTGC-30 and 50-TATACTCTGTAGTGTCACCT
GGCTG-30 for E3, 50-ACAGAACCCTAGTATTCAAC
CTGC-30 and 50-GACAGCGACATGAACTTAAGTG
AG-30 for E4 and 50-ACTCTCTTCCGCATCGCTGT-30
and 50-GTGACTGGTTAGACGCCTTTCT-30 for MLP.
PCR products were analyzed as described earlier.
Luciferase assays
Cells were lysed with Luc lysis buffer (25mM Tris–HCl
[pH 7.9], 1% Triton X-100 and 10% glycerol). The cell
lysates and a ﬁreﬂy luciferase substrate (Promega) were
mixed, and the luciferase activity was measured by
Lumat LB9506 (BERTHOLD). The protein concentra-
tion of cell lysates was determined by the Bradford
method, and the luciferase activity was normalized by
the protein concentration. Mean values with SD were
obtained from three independent experiments.
Western blotting
For checking the expression level of TAF-I and b-actin,
cell lysates were prepared using lysis buffer for ChIP
assays. Nuclear/cytoplasmic fractions were prepared as
described earlier. Cell lysates or nuclear/cytoplasmic frac-
tions were subjected to SDS–PAGE, and then proteins
were transferred to a PVDF membrane (Millipore). The
membranes were blocked with 5% skim milk/TBST
(Tris-buffered saline containing 0.1% Tween-20) at room
temperature, and then incubated with indicated primary
antibodies at room temperature. After washing with
TBST, the membranes were incubated with antimouse or
rabbit IgG antibodies conjugated with horseradish perox-
idase (GE healthcare) at room temperature, followed by
washing. The blots were developed using Chemi-Lumi
One (Nacalai tesque).
RESULTS
The structure of viral chromatin in infected cells
The Ad DNA forms a chromatin-like complex with viral
core proteins in virions and remains associated with
protein VII in the nucleus during early phases of infection
(9,10). Several lines of evidence suggest that cellular
histones are incorporated into viral chromatin in early
phases of infection (25–27), but the actual structure of
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clarify how viral chromatin structure changes to be a
template for viral early transcription after the entry
into the nucleus, we ﬁrst performed ChIP assays with
antiprotein VII, antihistone H3, antiacetylated H3
(AcH3) and anti-FLAG (for negative control) antibodies
(Figure 1). The antibody against AcH3 used in this study
speciﬁcally recognizes acetylated K9 and/or K14 of
histone H3, both of which are markers for active chroma-
tin (30). HeLa cells were infected with HAdV5 at an MOI
(multiplicity of infection) of 100. Infected cells were
cross-linked with formaldehyde and then sonicated to
release chromatin fragments. The average size of DNA
puriﬁed from chromatin fragments was <1kb (data not
shown). Viral DNA replication occurs  8hpi (hours post
infection) (data not shown) (10). Viral core proteins are
encoded by late genes, which are expressed only after viral
DNA replication, and newly synthesized core proteins are
likely to be localized throughout the nucleus in late phases
of infection (31). Therefore, to eliminate the effect of viral
DNA replication and/or late gene expression on the struc-
ture of viral (and/or cellular) chromatin, hydroxyurea
(HU), a replication inhibitor, was added in the case of
10hpi. We conﬁrmed that the addition of HU gives no
effect on the structure of viral chromatin in the earlier
time of infection (Supplementary Figure S1A).
Figure 1. Viral chromatin structure in early phases of infection. (A) The illustration of the structure of Ad genome. Arrows represent each promoter
region of viral genes. Target region of primer set for Hexon is indicated as a bar. (B) ChIP assays using quantitative PCR (qPCR). HeLa cells were
infected with HAdV5 at an MOI of 100 and harvested at 1, 2, 4, 6 or 10 hpi. In the case of 10hpi, HU was added right after infection to prevent
viral DNA replication. The cells were cross-linked by formaldehyde and lysed. The lysates were subjected to immunoprecipitation with antibodies
against histone H3, acetylated histone H3 (AcH3), protein VII and FLAG. qPCR was performed with primers for ﬁve regions of the viral genome
(the E1A promoter region, E1A pro; the E3 promoter region, E3 pro; the E4 promoter region, E4 pro; major late promoter region, MLP; and hexon
ORF region, Hexon) and immunoprecipitated DNA as templates. (C) Re-ChIP assays with antiprotein VII antibody. HeLa cells were infected with
HAdV5 at an MOI of 100 and harvested at 6hpi. The cells were subjected to ﬁrst ChIP using anti-FLAG (lanes 4–7) or antiprotein VII (lanes 8–11)
antibodies, and the immunoprecipitated complex was then subjected to the second ChIP with anti-FLAG (lanes 5 and 9), antihistone H3 (lanes 6 and
10) and anti-AcH3 (lanes 7 and 11) antibodies. For lanes 4 and 8, DNAs puriﬁed from 10% of the ﬁrst immunocomplexes were used as template.
Immunoprecipitated DNA was ampliﬁed by semi-quantitative PCR using primer sets for E1A pro (upper panel) and MLP (lower panel). PCR
products were separated on a 7% polyacrylamide gel and visualized by staining with EtBr. Input DNAs (lanes 1–3) were puriﬁed from 0.2, 0.05 and
0.0125% of cell lysates used for ﬁrst ChIP. (D) Re-ChIP assays with anti-RNA polymerase II (pol II) antibody. Re-ChIP assays were performed as
described in (C), except that anti-pol II antibody was used for the ﬁrst immunoprecipitation (lanes 8–11).
892 Nucleic Acids Research, 2011,Vol. 39,No. 3We selected ﬁve regions for ChIP assays, three early
gene promoters (E1A pro, E3 pro and E4 pro), one late
gene promoter (MLP), and the central region of the viral
genome (ORF region of hexon, Hexon, Figure 1A). MLP
and Hexon regions are included in the transcription unit
of E2 gene, one of viral early genes, on the opposite strand
(Figure 1A). However, MLP was not fully activated in
early phases of infection under the condition employed
here. By RT–qPCR assays with a primer set for ampliﬁ-
cation of the region just downstream of the transcription
start site, we could not detect mRNAs transcribed from
MLP in early phases of infection (unpublished data). In
addition, USF1 and USF2, transcription factors known to
regulate the transcription from MLP (32), were not re-
cruited to this region in early phases of infection. (unpub-
lished data). As reported earlier (10), protein VII
was bound throughout the viral genome so far tested
(Figure 1B, VII). The binding level of protein VII was
slightly changed in the course of infection, and the
binding of protein VII was observed up to 10hpi at
least. These results suggest that protein VII is a compo-
nent of viral chromatin during early phases of infection. It
was also shown that histone H3 is bound throughout the
viral genome with a gradual increment (Figure 1B, H3).
The binding of histone H2A-H2B and H4 to viral chro-
matin was also detected by ChIP assays using anti-H2A-
H2B and anti-H4 antibodies, and the ratio of each core
histone bound on viral chromatin was comparable to that
on cellular chromatin, although the binding levels of core
histones on viral chromatin were lower than those on
cellular chromatin (Supplementary Figure S1B and C,
and see ‘Discussion’ section). These results indicate that
viral chromatin contains, at least partly, the canonical nu-
cleosomes in infected cells. In ChIP assays with
antiprotein VII antibody, no signals were detected by
PCR using primer sets for cellular chromatin
(Supplementary Figure S1C), reﬂecting the speciﬁcity of
this antibody. The binding of histones and protein VII to
viral chromatin was also detected by ChIP assays using
cells infected at lower MOI (MOI of 5, data not shown).
These results suggest that not only viral protein VII, but
also cellular histones are associated with the viral genome
DNA in early phases of infection. The binding level
of AcH3 was also increased as infection proceeded
(Figure 1B, AcH3). The binding of histone H3 and acetyl-
ation of histone H3 were also observed at other regions of
the viral genome (Supplementary Figure S1D).
Although our ChIP assays clearly indicate that both
protein VII and histones are bound with viral chromatin
in early phases of infection, it is also possible that protein
VII and histones are bound to two different chromatin
templates independently. To examine whether both
protein VII and histones are components of the same
viral chromatin in infected cells, we performed re-ChIP
assays (Figure 1C). At 6hpi, infected HeLa cells were
ﬁxed and ﬁrst immunoprecipitated using anti-FLAG or
antiprotein VII antibodies. Then, the immunocomplexes
were released from the ﬁrst antibody and subjected to the
second immunoprecipitation using anti-FLAG, anti-H3
or anti-AcH3 antibodies. Histone H3 was detected on
the protein VII-bound viral chromatin (Figure 1C, lane
10), indicating that both protein VII and histones are
associated with the same viral genome DNA in early
phases of infection. In addition, the binding of AcH3
was detected on the protein VII-bound viral chromatin
at the high level around the E1A promoter, but at
the low level around MLP (Figure 1C, lane 11). This
pattern was in parallel with that of normal ChIP assays
(Figure 1B), and acetylation of histone H3 is highly
correlated to viral transcription (Figure 2B, see below).
To examine more directly whether AcH3 is bound with
active viral chromatin, we performed re-ChIP assays using
anti-RNA polymerase II (pol II) antibody (Figure 1D and
Supplementary Figure S1E). The binding of AcH3 was
also observed on the pol II-bound viral chromatin as
was the case for re-ChIP assays using antiprotein VII
antibody, indicating that AcH3 is indeed a component
of active viral chromatin in infected cells. Taken
together, we conclude that in early phases of infection,
viral chromatin is associated with both viral protein VII
and cellular histones, and this ‘chimeric’ chromatin
functions as a template for viral early transcription.
Acetylation of histone H3 occurs in the absence of
transcription at active promoter regions
Using ChIP assays with anti-AcH3 antibody, we observed
the gradual increment of the binding of AcH3 on viral
chromatin (Figure 1B). This acetylation pattern could be
correlated with the transcription state, because the acetyl-
ation level of histone H3 at the E1A promoter, which is
the ﬁrst activated promoter, was higher than that of other
regions (Figure 1B, also see Figure 2B). The binding level
of AcH3 at the promoter regions of other early genes,
which are active in early phases of infection, was also
higher in earlier infection periods than that at inactive
(late) gene promoters (Supplementary Figure S1D). This
gives rise to the possibility that acetylation of histone H3
has a role in viral early transcription. Alternatively, this
acetylation might be a consequence of ongoing transcrip-
tion because AcH3 was detected even at inactive pro-
moters and other regions in the later time of infection
(Figure 1B, MLP and Hexon, and Supplementary
Figure S1D), all of which are present in the transcription
units of other viral active genes (Figure 1A). Therefore, to
examine the relationship between ongoing transcription
and acetylation of histone H3, we performed ChIP
assays using cells cultured in the presence of a-amanitin,
which blocks pol II-mediated transcription (Figure 2A).
Histone H3 as well as protein VII were found associated
with the viral DNA in the presence of a-amanitin
(Figure 2A, H3 and VII). We also observed the efﬁcient
acetylation of histone H3 at early gene promoters in the
presence of a-amanitin (Figure 2A and B, E1A pro, E3
pro and E4 pro and Supplementary Figure S1D).
However, in the presence of a-amanitin, the acetylation
level of H3 at regions other than early gene promoters
was much less than that in the absence of a-amanitin
(Figure 2A and B, MLP and Hexon, and Supplementary
Figure S1D). These results suggest that acetylation of
histone H3 efﬁciently occurs at the promoter regions of
early genes even in the absence of ongoing transcription,
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tion at regions other than early gene promoters. It is noted
that the binding of protein VII was decreased gradually in
the presence of a-amanitin (Figure 2A, VII). Recently, a
microscopic analysis suggested that the addition of
a-amanitin inhibits the release of protein VII (33). The
results obtained here differ somehow from those from
the previous report, but the exact reason for this contra-
diction is unclear at present (‘Discussion’).
TAF-I is required for viral transcription, but not for the
binding of histone H3 and AcH3
TAF-I is one of the remodeling factors for core protein–
DNA complexes and forms ternary complexes on the viral
DNA through the interaction with protein VII in vitro and
in vivo (10). TAF-I plays an important role in viral gene
expression during early phases of infection because KD of
TAF-I expression results in the reduction of viral mRNA
levels (19). TAF-I is also reported to regulate cellular gene
expression through its histone chaperone activity or as a
component of INHAT (21,22). Therefore, it is possible
that TAF-I contributes to viral transcription through the
regulation of the binding and/or acetylation of histones on
viral chromatin. To test this possibility, we used TAF-I
KD HeLa cell lines we had established previously (19).
The expression level of TAF-I in KD cell lines (clone 4)
was reduced to  10% relative to that in HeLa cells,
whereas WT cell lines (clone 7) showed the almost same
expression level of TAF-I compared with HeLa cells
(Figure 3A). These cell lines were infected with HAdV5
at an MOI of 100 and subjected to RT–qPCR assays at
4hpi (Figure 3B and Supplementary Figure S2A). The
mRNA levels of viral early genes in KD cell lines were
 50% of that in WT cell lines, as reported earlier (19). At
the same time point, we also performed ChIP assays
(Figure 3C). However, the binding level of histone H3,
AcH3 and protein VII was the almost same in two cell
lines (Figure 3C, H3, AcH3 and VII). These results
indicate that TAF-I is required for viral early gene tran-
scription but not for the binding of histone H3 or acetyl-
ation of histone H3 K9/14 on viral chromatin. It is also
suggested that TAF-I does not strip protein VII of viral
chromatin, but rather stably forms ternary complexes on
viral chromatin to regulate viral transcription (10). By
re-ChIP assays, we found that AcH3 is also bound to
the TAF-I-bound viral chromatin at the high level
around the E1A promoter, but not around MLP
(Supplementary Figures S1E and 2B), conﬁrming that
TAF-I functions on the ‘chimeric’ viral chromatin.
Positive role of protein VII in infected cells
It was shown that protein VII–viral DNA complex
supports only a low level of transcription in cell-free
systems (11,12). In addition, protein VII was suggested
to function as a repressive factor in Xenopus oocytes
(13). However, as described earlier, protein VII remains
bound with viral chromatin in infected cells. Therefore, we
hypothesized that protein VII may have a potential role
for viral transcription and TAF-I is required for its
process. To test this, we puriﬁed TP-DNA (naked viral
DNA covalently bound with TP) and Ad-core (TP-DNA
with core proteins) from virions and used for transfection
of HeLa cells. The quality of Ad-core and TP-DNA was
conﬁrmed by silver staining of proteins in samples and
Figure 2. Effect of transcription on viral chromatin. (A) ChIP assays in the presence of a-amanitin. HeLa cells were infected with HAdV5 at an MOI
of 100 and incubated in the presence of 25mg/ml of a-amanitin. The cells were harvested at 2, 6 or 10 hpi, and cell lysates were subjected to ChIP
assays as described earlier. (B) Relative acetylation levels of histone H3. The level of AcH3 in the absence (Figure 1B) or presence of a-amanitin (2A)
was normalized by that of H3 [ratio (AcH3/H3)].
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(Supplementary Figure S3). Transfected cells were sub-
jected to ChIP assays (Figure 4A). ChIP assays revealed
that the viral DNA was associated with protein VII,
histone H3 and AcH3 in Ad-core-transfected cells, as
was the case in infected cells (Figure 4A, lanes 16–24).
On the other hand, in TP-DNA-transfected cells, only a
trace level of association of AcH3 was detected at 24hpt,
while histone H3 was bound at the comparable level to
that of Ad-core-transfected cells at all time points tested
here (Figure 4A, lanes 1–6). In Ad-core-transfected cells,
the amount of input DNA at 24hpt was more than that of
16 hpt (Figure 4A, lanes 29 and 30). This increment of
input DNA was due to viral DNA replication because the
addition of HU suppressed it (data not shown). We also
performed RT–PCR assays at 12 and 24 hpt (Figure 4B)
and found that the expression level of viral mRNAs in
Ad-core-transfected cells was much higher than that in
TP-DNA-transfected cells, while that of b-actin mRNA
remains unchanged in both cells (Figure 4B, lanes 7, 8,
10 and 11). It is noted that in Ad-core-transfected cells,
mRNA of MLP was detected only at 24 hpt (Figure 4B,
lane 11) and this expression was dependent on viral DNA
replication (data not shown), indicating that cells trans-
fected with Ad-core could reproduce the expression
pattern of viral genes in infected cells. These results
strongly suggest that protein VII can enhance viral gene
expression in infected cells. This could be due to high
efﬁciency of nuclear transport and/or high stability of
the viral DNA bound with core proteins. To address
this possibility, we analyzed the amount of the viral
DNA in cytoplasmic and nuclear fractions of transfected
cells (Figure 4C). HeLa cells were transfected with
Ad-core or TP-DNA and cultured in the presence of
HU to prevent viral DNA replication. At 12 and 24hpt,
transfected cells were harvested and separated into
cytoplasmic and nuclear fractions. The separation was
conﬁrmed by western blotting with anti-Hsp90 (for cyto-
plasmic marker) and antihistone H3 (for nuclear marker)
antibodies (Figure 4C, upper panels). Viral DNA was
puriﬁed from each fraction and analyzed by PCR with
speciﬁc primers for viral DNA (Figure 4C, lower panel).
We found that the amount of the viral DNA in nuclei of
Ad-core-transfected cells was comparable to that in nuclei
of TP-DNA-transfected cells (Figure 4C, lower panel,
lanes 1–3, 7–9, 13–15 and 19–21), indicating that protein
VII is not likely to enhance the nuclear transport and the
stability of the viral DNA.
Protein VII enhances transcription initiation
It was reported that protein VII could interact with E1A
protein, a transactivator for viral early gene transcription
(13). Based on this, a model was proposed that protein VII
recruits E1A protein to viral chromatin, leading to the
upregulation of viral early gene transcription. Therefore,
the transcription enhancement effect of core proteins seen
in Figure 4 might be brought from the interaction between
protein VII and E1A protein. Alternatively, if protein VII
could enhance transcription with its own property, the
transcription enhancement effect could be observed inde-
pendent of the presence of Ad proteins and/or adenoviral
DNA sequences. Thus, to examine the direct effect of
protein VII on transcription in the absence of any Ad
gene products and DNA sequences, we reconstituted
protein VII–DNA complexes using recombinant protein
VII (Figure 5A, left panel) and a non-adenoviral
plasmid DNA (pSV-Luc, Figure 5B), which contains the
luciferase gene as a reporter. The reconstituted complexes
were ﬁrst analyzed by an agarose gel electrophoresis
(Figure 5A, right panel). By the addition of increasing
amounts of protein VII, plasmid DNA did not enter the
gel, indicating that protein VII forms nucleoprotein
complexes (or aggregates) with pSV-Luc (Figure 5A,
right panel, compare lanes 2 with lanes 3–8). To
examine whether protein VII have a positive role in tran-
scription, the reconstituted complexes were transfected in
HeLa cells, and the luciferase activity was measured at
24hpt (Figure 5C). As shown in Figure 5C clearly, the
addition of protein VII enhanced the luciferase activity.
When 100ng of protein VII was added to 100ng of
pSV-Luc, the luciferase activity was increased to the
maximal level (5- to 6-fold) compared with the case of
pSV-Luc alone. This result indicates that protein VII
is able to enhance transcription in the absence of any
Ad products. We also found that protein VII could
enhance transcription from a reporter plasmid regulated
by Ad enhancer/promoter (Supplementary Figure S4A),
Figure 3. Effect of knockdown of TAF-I expression on viral chroma-
tin. (A) Expression level of TAF-I in KD cell lines. Western blot
analyses were performed with lysates from HeLa cells (lane 1), KD
cell lines clone 4 (lane 2) or clone 7 (lane 3). (B) RT–qPCR assays.
KD cell lines clone 4 and 7 were infected with HAdV5 at an MOI of
100 and total RNAs were puriﬁed at 4 hpi. cDNAs were synthesized
with reverse transcription and subjected to qPCR using primer sets for
E1A, E3, E4 and b-actin mRNAs. Viral mRNA levels were normalized
by b-actin mRNA level and graphed. (C) ChIP assays. KD cell lines
clone 4 and 7 were infected with HAdV5 at an MOI of 100. At 4hpi,
cells were collected and subjected to ChIP assays as described in the
legend for Figure 1B.
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sequence-speciﬁc.
Next, to examine the effect of protein VII on the chro-
matin structure of transfected DNA, we performed ChIP
assays with several antibodies (Figure 5D). We chose two
regions for this ChIP assay; one is the promoter region
(SV40 pro) upstream of the luciferase ORF, and the other
is the ORF region of b-lactamase gene (Amp ORF), which
is thought not to be transcribed in transfected cells. We
found that protein VII is still bound to the plasmid DNA
in transfected cells when mixed prior to transfection
(Figure 5D, VII). We also found that TAF-I is bound to
the plasmid DNA only when transfected together with
protein VII (Figure 5D, TAF-I). In contrast, histone H3
was detected independently of the presence of protein VII
(Figure 5D, H3). We also performed ChIP assays with
anti-Sp1 antibody because the SV40 promoter contains
several Sp1-binding sites (34). The binding level of Sp1
at the SV40 promoter was increased >2-fold in the
presence of protein VII, suggesting that the enhancement
of transcription by protein VII is at least in part due to the
increase of Sp1 recruitment, that is, one of important tran-
scription initiation steps (Figure 5D, Sp1). Taken
together, these results suggest that protein VII increases
the initiation level of transcription, resulting in transcrip-
tion enhancement. To examine the effect of protein VII on
the transfection efﬁciency and/or DNA stability, the
reconstituted complexes were transfected in HeLa cells,
and at 24hpt, transfected cells were separated into cyto-
plasmic and nuclear fractions as performed in Figure 4C.
The amounts of pSV-Luc in nuclear fraction were
quantiﬁed using qPCR with primers for the SV40
promoter (Figure 5E and Supplementary Figure S4B).
The amount of pSV-Luc in the nucleus was the almost
same regardless of the presence of protein VII, indicating
that protein VII does not enhance the transfection efﬁ-
ciency and/or DNA stability under this condition.
Involvement of TAF-I in enhancement effect by
protein VII
Finally, to examine whether TAF-I is needed in protein
VII-mediated enhancement of transcription, KD of TAF-I
Figure 4. Ad-core/TP-DNA transfection assays. (A) ChIP assays of viral chromatin in transfected cells. HeLa cells were transfected with TP-DNA
(left three panels) or Ad-core (right three panels). At 8, 16 and 24hpt, cells were collected, and cell lysates were subjected to ChIP assays using
indicated antibodies. Semi-quantitative PCR was performed using primer sets for E1A pro, E4 pro or MLP and immunoprecipitated DNA as
templates. PCR products were separated on a 7% polyacrylamide gel and visualized by staining with EtBr. Input DNAs (lanes 13–15 and 28–30)
were puriﬁed from 2% of cell lysates used for ChIP. (B) Semi-quantitative RT–PCR assays. HeLa cells were transfected with Ad-core (Ad; lanes 2, 5,
8 and 11), TP-DNA (TP; lanes 1, 4, 7 and 10), or mock-DNA (Mo; lanes 3, 6, 9 and 12), and total RNAs were puriﬁed at 12 (lanes 1–3 and 7–9) and
24 hpt (lanes 4–6 and 10–12). cDNAs were synthesized without (lanes 1–6) or with (lanes 7–12) reverse transcription. Semi-quantitative PCR was
performed using primer sets for E1A, E4, MLP and b-actin mRNAs. PCR products were analyzed as described in the legend for (A). (C) The
amount of nuclear and cytoplasmic viral DNA in transfected cells. Ad-core and TP-DNA were used for transfection (100ng DNA) into HeLa cells.
Transfected cells were cultured in the presence of HU to prevent viral DNA replication. At 12 (lower panel, lanes 1–12) and 24hpt (lanes 13–30),
nuclear and cytoplasmic fractions were prepared from Ad-core- (lower panel, lanes 1–6 and 13–18), TP-DNA- (lanes 7–12 and 19–24), and
mock-transfected cells (lanes 25–30) as described in ‘Materials and Methods’ section. To conﬁrm the separation of each fraction, nuclear (upper
panels, lanes 1, 3, 5, 7 and 9) and cytoplasmic fractions (lanes 2, 4, 6, 8 and 10) were subjected to western blot analyses using antihistone H3 and
anti-Hsp90 antibodies for nuclear and cytoplasmic marker proteins, respectively. The viral DNA of nuclear (lower panel, lanes 1–3, 7–9, 13–15, 19–
21 and 25–27) and cytoplasmic fractions (lanes 4–6, 10–12, 16–18, 22–24 and 28–30) was ampliﬁed by semi-quantitative PCR with a primer set for
the MLP region. PCR products were analyzed as described in the legend for (A). For each fraction, 4-fold serial dilution (1, 1/4 and 1/16 volume)
was used as templates for PCR.
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TAF-I, siTAF-I. The expression level of TAF-I in
siTAF-I-treated cells was decreased to  10% of that in
control siRNA (siControl)-treated cells (Figure 6A).
siTAF-I- or siControl-treated cells were transfected
with pSV-Luc alone or with protein VII, and then the
effect of TAF-I KD on the chromatin structure of
transfected DNA and the recruitment of Sp1 to the
promoter were examined (Figure 6B). TAF-I KD
resulted in slight change of the binding level of histone
H3 (Figure 6B, H3). In siControl-treated cells, protein
VII could enhance the binding of Sp1 at the promoter
region, as described earlier (Figure 6B, Sp1). In contrast,
when siTAF-I-treated cells were transfected with
protein VII–DNA complex, protein VII could not
enhance Sp1 binding, while the binding level of protein
VII was almost the same in both cells (Figure 6B, VII
and Sp1). When cells were transfected with pSV-Luc
alone, the recruitment of Sp1 to the promoter was
not affected by TAF-I KD, indicating that TAF-I is
not directly involved in Sp1 recruitment (Figure 6B,
Sp1), but TAF-I is required for the recruitment of the
transcription factor when protein VII is present.
Therefore, it is suggested that the enhancement effect by
protein VII is due to ternary complex formation with
TAF-I.
Figure 5. Reconstitution of protein VII–DNA complexes. (A) Electrophoresis mobility shift assays. Left panel shows Coomassie Brilliant Blue
staining of recombinant protein VII (100ng, lane 2) separated by a 12.5% SDS–PAGE. Lane 1 shows molecular size markers (M). pSV-Luc
(100ng) was incubated at 37 C for 15min in the absence (right panel, lane 2) or presence of protein VII (25, 50, 100, 200, 300, 400ng for lanes
3, 4, 5, 6, 7 and 8, respectively). The samples were separated on a 1% agarose gel in 0.5 TBE buffer, and DNAs were visualized by staining with
EtBr. Lane 1 shows DNA size markers (M). (B) The illustration of the pSV-Luc structure. Filled triangle and open boxes represent the promoter
region and the ORF region, respectively. Two black bars are target regions for ChIP assays. (C) Luciferase assays. HeLa cells were transfected with
the reconstituted complexes shown in (A). At 24hpt, cell lysates were prepared, and the luciferase activity was measured. (D) ChIP assays. pSV-Luc
(100ng) was incubated without (DNA alone) or with protein VII (100ng) and used for transfection into HeLa cells as described in (A). At 24hpt,
cells were harvested, and cell lysates were subjected to ChIP assays. qPCR was performed using primer sets for SV40 promoter (SV40 pro) and ORF
region of b-lactamase gene (Amp ORF) and immunoprecipitated DNA as templates. Note that the binding level of Sp1 is calculated as fold
enrichment relative to negative control (anti-FLAG antibody) and then normalized by that at Amp ORF in naked DNA-transfected cells.
(E) The amount of pSV-Luc in the nucleus of transfected cells. Cells transfected as described in (D) was harvested at 24 hpt, and nuclear and
cytoplasmic fractions were prepared as performed in Figure 4C. DNAs recovered from nuclear fraction were subjected to qPCR using primer sets for
SV40 pro and b-actin gene (for cellular genome number). The amounts of pSV-Luc in the nucleus were normalized by cellular genome number and
graphed.
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Several previous reports suggested the possible structure
of viral chromatin in infected cells, but the exact structure
remains unclear. ChIP and re-ChIP assays in this study
clearly showed that cellular histones as well as protein VII
are associated with the almost entire region of viral chro-
matin during early phases of infection and this ‘chimeric’
chromatin functions as a template for viral early transcrip-
tion (Figure 1 and Supplementary Figure S1). It is noted
that the binding levels of core histones were lower than
those on cellular chromatin (Supplementary Figure S1C).
The lower nucleosome density in early phases of infection
was also reported in the cases of herpes simplex virus type
1 and human cytomegalovirus (35–37). Thus, this might
be a common feature for some DNA viruses during lytic
infection cycles. We also found that on viral chromatin,
acetylation of histone H3 occurs in a good correlation
with viral transcription (Figure 2B). Recently, these
dynamic changes of histone modiﬁcations linked with
transcription were also observed in other DNA viruses,
such as SV40 and herpes simplex virus type 1 (38,39).
Therefore, the transcription regulation coupled with
histone modiﬁcation could also be a general mechanism
for DNA viruses. Post-translational modiﬁcation of
histones contributes to some local changes of the chro-
matin structure and/or functions as a speciﬁc target for
chromatin-binding factors (30). Among a variety of
histone modiﬁcations, acetylation at K9 and/or K14 of
histone H3 is recognized as an ‘active’ chromatin mark
for transcription. On the adenoviral chromatin, acetyl-
ation of histone H3 occurs in two fashions, i.e. in a
transcription-independent manner observed at active
promoter regions and dependent manner seen at other
regions (Figure 2 and Supplementary Figure S1D).
Because the transcription inhibition by a-amanitin did
not affect the acetylation level of histone H3 at active
promoter regions (Figure 2B), this acetylation could
occur actively at these regions, although the exact role
of this acetylation in viral transcription is unclear at
present. On the other hand, the acetylation at the
regions within the transcription units (including inactive
promoters) is largely dependent on transcription
(Figure 2B), suggesting that the acetylation occurs being
coupled with elongation of RNA polymerase II, as the
case reported in SV40 (38). We also observed other
histone modiﬁcation correlated with viral transcription
in infected cells (unpublished data). These results suggest
the possibility that the chromatin structure and/or histone
modiﬁcation have a role in viral transcription, as is the
case for cellular chromatin. It is also worthwhile to note
that the addition of a-amanitin causes a drastic reduction
of the binding level of protein VII (Figure 2A). This result
may suggest that transcription contributes to the mainten-
ance of the viral chromatin structure. It was reported that
nuclear dots formed by protein VII are abolished during
viral transcription and the addition of a-amanitin inhibits
it (33). This report proposed that transcription releases
protein VII from viral chromatin. This report, however,
did not address the localization of the viral DNA in
the course of infection. It is possible that the intracellular
localization of the viral DNA is changed together with
protein VII as viral transcription proceeds, and thus
nuclear dots formed by protein VII may disappear. If
so, the addition of a-amanitin might inhibit the localiza-
tion changes of protein VII and the viral DNA rather than
the release of protein VII, resulting in the remaining
nuclear dots. We have shown here that protein VII
could be a component of the template for viral early
gene transcription (Figure 1C) and has a positive role in
transcription (Figures 4 and 5). We also observed using
ChIP assays that in the presence of HU, protein VII
remains associated with viral chromatin even at 16hpi
(data not shown). Therefore, we conclude that protein
Figure 6. Effect of knockdown of TAF-I expression on Sp1 recruit-
ment. (A) Expression level of TAF-I. Western blot analyses were per-
formed with lysates from HeLa cells treated with control siRNA
(siControl, lanes 1–3) or siRNA for TAF-I (siTAF-I, lane 4). For
siControl-treated cells, 25% (lane 1) and 50% (lane 2) volume of
lysate were also loaded. (B) Transfection of siRNA-treated cells with
reconstituted protein VII–DNA complexes. siControl- or
siTAF-I-treated cells were transfected with reconstituted protein VII–
DNA complexes, and cell lysates were subjected to ChIP assays as
described in Figure 5D. P-values are calculated using Student’s t-test.
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phases of infection, although we could not exclude the
possibility that protein VII is released from some speciﬁc
region or a minor population of viral chromatin. We also
could not rule out the possibility that some population of
protein VII is replaced by histones, since the binding level
of histone H3 is gradually increased and that of protein
VII is reciprocally decreased at some region even in the
absence of a-amanitin (e.g. Figure 1B, MLP).
TAF-I, a remodeling factor for protein VII–DNA
complexes, has a histone chaperone activity and
reported to regulate cellular gene expression through its
activity (21). However, KD of TAF-I expression resulted
in no effect on the binding level of histone H3 on viral
chromatin (Figure 3C). Our preliminary data suggest that
other histone chaperones seem to be involved in histone
deposition onto viral chromatin (unpublished data). Thus,
it is suggested that the role of TAF-I in viral transcription
is unlikely to depend on its histone chaperone activity,
although we could not exclude the possibility that
TAF-I regulates the structure and/or the binding mode
of nucleosome on viral chromatin. In addition, the acetyl-
ation level of H3 on viral chromatin was not affected by
TAF-I KD, although TAF-I is also reported as a compo-
nent of INHAT (22). pp32, also a component of INHAT
(22), is reported to be associated with viral chromatin (31)
and it is reported that HDAC1 (histone deacetylase 1)
forms a complex with TAF-I and pp32 (40). However,
KD of pp32 expression has no effect on the binding
level of AcH3 on viral chromatin like TAF-I KD (data
not shown). We observed that the addition of trichostatin
A, a HDAC inhibitor, affected neither the viral mRNA
levels nor the binding level of AcH3 on viral chromatin
(data not shown). Therefore, it is likely that TAF-I and
pp32 (and HDAC1) are not involved in viral transcription
as components of INHAT.
We also showed a functional role of protein VII in cells
(Figures 4 and 5). Previously, it was reported that protein
VII shows a negative effect on transcription when ex-
pressed in Xenopus oocytes (13). In their condition,
however, the expression level of protein VII relative to
the DNA amount was not well considered. In our condi-
tion, protein VII was mixed together with DNA and then
introduced into cells. The enhancement effect reached the
maximal level when protein VII and DNA were mixed at
the equal weight ratio (1:1) (Figure 5C). This ratio
( 30.8bp/one protein VII molecule) is close to that of
the virion ( 36000bp/833 copies of protein VII
(41)=43.2bp/one protein VII molecule). In the condition
employed here, the import level of the viral DNA into the
nucleus was not enhanced by protein VII (Figures 4C
and 5E). Hindley et al. (42) reported using semi-in vitro
assays that protein VII is imported by transportin into the
nucleus through NPC and a transportin inhibitor inhibits
the nuclear import of the viral DNA, and proposed that
the import of the viral DNA is coupled with the
transportin-mediated import of protein VII. We may
consider an alternative nuclear import pathway for trans-
fected Ad-core. In the case of infection, virions are ﬁrst
attached to NPC through the interaction with CAN/
Nup214, and then the nuclear import of Ad-core occurs
concomitantly with the disassembly of the virion (7). It is
quite likely that a viral component(s) other than protein
VII is involved in this coupling process. Thus, the nuclear
import of transfected Ad-core or reconstituted protein
VII–DNA complexes could be different from that of
Ad-core released from virions at NPC.
It was reported that transiently transfected plasmid
DNA does not show the clear nucleosome ladders when
digested with MNase, although core histones bind to the
transfected DNA (43). It is possible that histones are de-
posited on transfected DNA randomly, resulting in some
negative effect on the template activity. Therefore, naked
DNA (TP-DNA or pSV-Luc alone) could be subjected to
the random deposition of histones, and thus show lower
level of transcription in cells (Figures 4B and 5C). On the
other hand, protein VII might regulate the chromatin
structure in cis to escape from or overcome the negative
effect by histone deposition, although the detailed mech-
anism remains unclear at present. One possible mechanism
is that protein VII protects DNA from random deposition
of histones because biochemical analyses indicated that
protein VII on the DNA inhibits the nucleosome forma-
tion locally (data not shown). Protein VII alone, however,
could not enhance transcription and TAF-I is needed
in this process since TAF-I KD reduced the enhancement
effect of protein VII (Figure 6B). We previously reported
using biochemical analyses that TAF-I remodels protein
VII–DNA complexes to make them more accessible for
transcription factors, and enhances transcription from
Ad-core, at least by facilitating the formation of the tran-
scription initiation complex (11,18,20). In good agreement
with this, protein VII, together with TAF-I, enhances
transcription in cells at least in part by increasing the re-
cruitment of transcription factors, one of the important
steps of the transcription initiation (Figure 5D). Taken
together, we would propose a possible mechanism that
protein VII could protect cis elements essential for tran-
scription (including the binding sites of transcription
factors) from random deposition of histones, but keep
the accessibility of trans-acting factors to these regions
through the remodeling by TAF-I (Figure 7). We specu-
late that this chromatin structure organized by protein VII
leads to and/or coordinates with proper deposition of
histones and/or histone modiﬁcations on viral chromatin,
resulting in efﬁcient viral transcription in early phases of
infection. Thus, protein VII could establish the chromatin
structure competent for transcription. Consistent with this
idea, we observed using in vivo footprinting assays that the
chromatin structure surrounding the promoter region in
the presence of protein VII differs from that in the absence
of protein VII (data not shown). It was also reported
that linker histone H1, but not core histones, is poorly
associated with transiently transfected DNA (43).
Histone H1 was reported to have an important role in
the disassembly of the Ad virion and the nuclear import
of Ad genome through NPC, possibly by interacting with
hexon, one of capsid proteins (7). Therefore, it is import-
ant to ask whether histone H1 binds to viral chromatin
and plays a role in viral transcription.
In this report, we have shown a functional role of viral
chromatin in the regulation of viral gene expression in
Nucleic AcidsResearch, 2011, Vol.39,No. 3 899early phases of infection. The chromatin structure plays an
important role in DNA replication in eukaryote cells (44),
so that protein VII and/or histones might also have a role
in viral DNA replication. Thomas and Mathews showed
with superinfection experiments that the activation of late
genes requires viral DNA replication in cis (45). It is
reasonable to assume that during viral DNA replication,
viral chromatin undergoes some structural changes to be a
competent template for the late gene transcription. We
observed that histone H3 also binds to viral chromatin
in late phases of infection (unpublished data). Therefore,
it is possible that histones are incorporated into viral
chromatin during or after viral DNA replication and
have an important role in activation and regulation of
the late genes. The deposition mechanism of a tran-
scription factor(s) and histones during DNA replication
is to be an important key. Studies to clarify the structural
change of viral chromatin during viral DNA replication
and its role for the regulation of late gene expression are
needed.
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